Momenta Pharmaceuticals, Inc. (MNTA)

[Double_Bagel]

They have earned their bonuses! I would hate to see what an unproductive year would look like for MNTA. Even Baxter is walking away. Maybe EPRS and CHRS are better biosimilar plays here.

"2014 was a very productive year for Momenta. We successfully executed on many of our corporate objectives including the achievement of multiple development milestones in our biosimilars collaboration with Baxter, initiation of a Phase 2 clinical study of necuparanib in pancreatic cancer, and the introduction of three promising autoimmune pipeline candidates further broadening our novel drug portfolio," said Craig A. Wheeler, President and Chief Executive Officer of Momenta Pharmaceuticals.